Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Reverse Split
View:
Post by ragingbull1327 on May 29, 2015 11:21am

Reverse Split

Awesome.  How long will that take them?   10 years?    I'd be more inclined to vote for a 3:1 SPLIT, drive this to 0.10 and 500 million shares.   :)
Comment by Blockbuster on May 29, 2015 12:09pm
This post has been removed in accordance with Community Policy
Comment by txbioinv on May 29, 2015 5:51pm
Buster, gonna try and copy a letter sent to the good dr and mr olds. Cant even do an attachment here or on the pm screen. oh well
Comment by SWNE on May 29, 2015 6:42pm
Anyone with any stock market experience knows that reverse splits usually return to their original share price, losing major value. Go find another trough to feed from!
Comment by txbioinv on May 30, 2015 9:57am
LOL.............ole swinesaack has arisen. Do you have other ideas with no tute support? or do you want us taken out for nickels and dimes? grow a pair.............Welcome to the world of biotech.
Comment by cheetio on May 29, 2015 8:38pm
.....blame the shares outstanding........ha ha.........Lucara 379.52 million shares outstanding.... Close 2015-05-29 C$ 2.07......doin just fine
Comment by account15 on May 29, 2015 9:27pm
Reverse split is the most idiotic thing right now. I really hope you did not send this letter. See how AEZ on TSE -- Aeterna Zentaris shareholders take it in the ??? . FYI
Comment by txbioinv on May 30, 2015 9:40am
aezs has had multiple drug/phase 3 failures and is now under new leadership, you should try stating all the main facts.
Comment by loveshackdave on May 31, 2015 12:45am
"Reverse split is the most idiotic thing right now. I really hope you did not send this letter. See how AEZ on TSE -- Aeterna Zentaris shareholders take it in the ??? . FYI" Also see ONCS, they reverse split earlier this month, uplisted to NASDAQ last friday, and are up 42% since I purchased on the 21st. They also have about 12 months of cash left. Reverse splits are not somehow ...more  
Comment by terr2 on May 31, 2015 10:00am
( TST has been putting themselves infront of investment firm after investment firm trying to increase institutional interest.) You don't really believe that do you????? I believe the longer they can keep the SP low, the more retail invester's will give up and part with their shares. Just look at the volume lately. Little retailer's saying good-by. Who do you think is picking up their ...more  
Comment by txbioinv on May 30, 2015 9:55am
one year ski slope............2.07 vs .27 usd, lousy comparison
Comment by cheetio on May 31, 2015 12:18am
Another fairy tale fortune...present present present.....haaa
Comment by txbioinv on May 29, 2015 5:48pm
LOL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities